Back to Full Leadership Team
Chief Executive Officer
Robert comes to Ximedica with over 30 years of experience in leadership roles, most recently as the President of NxStage Kidney Care and CFO of NxStage Medical. After serving as CFO for seven years, he was appointed to lead the company’s entry into the dialysis service business. During his tenure, the company grew to over $400M in revenue (from $6M), to 3000 employees worldwide (from 100 employees), and improved gross margins to 50% (from -21%).
Previously, Robert enjoyed a 10 year finance career as VP Corporate Analysis & Control, VP International Finance, and Assistant Corporate Controller at Boston Scientific (NYSE: BSX), a worldwide $8B medical device company operating in 40 countries. A CPA with an MBA from the University of Michigan, Robert began his career at Deloitte & Touche, followed by 5 years at United Technologies (NYSE: UTX), a $57B multinational conglomerate and manufacturer of high technology products and provider of services to the building and aerospace industries.
Executive Vice President, Corporate Development
Tracy brings over 20 years of medical device and pharmaceutical business acumen to Ximedica’s leadership team. Her expertise in building healthcare businesses both organically and through M&A advances the growth plans for Ximedica, growing opportunities for our clients and our employees. With a broad range of roles and transactions with large companies such as Merck, Tracy brings the global perspective needed for Ximedica’s largest clients. Having served as CFO and VP of Business Development in the medical device startup space, she understands the need for creativity and flexibility that Ximedica’s startup clients need to succeed.
As EVP of Corporate Development, Tracy serves to identify, complete, and integrate Ximedica’s acquisitions into a sustainable and profitable strategy, supporting the growth of the larger organization as well as each and every employee.
Tracy holds a Bachelor of Engineering from The Cooper Union for the Advancement of Science and Art, and an MBA from Duke University (Fuqua School of Business).